$11.47
0.292.59%
Benzinga
Benzinga
Benzinga
금요일, 10월 16
Benzinga
© 2026 Benzinga | All Rights Reserved
Enanta Pharma (ENTA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.48 | $-0.48 | $-0.74 | $-1.06 |
| Actual | $-0.67 | $-0.45 | $-0.42 | $-0.87 |
| Surprise | -39.6% | +6.25% | +43.2% | +17.9% |
| Revenue | ||||
| Estimate | $17.1M | $17.2M | $15.4M | $15.8M |
| Actual | $14.4M | $17.2M | $18.6M | $15.1M |
| Surprise | -16.0% | -0.16% | +20.7% | -4.41% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.78 | $-0.44 | $-0.59 | $-0.57 |
| Revenue | ||||
| Consensus | $15.5M | $15.8M | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q3 | Aug 10, 2026 | $-0.67 | $-0.48 | -39.6 % |
| Q2 | May 11, 2026 | $-0.45 | $-0.48 | 6.25 % |
| Q1 | Feb 9, 2026 | $-0.42 | $-0.74 | 43.2 % |
| Q4 | Nov 17, 2025 | $-0.87 | $-1.06 | 17.9 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q3 | Aug 10, 2026 | $14.36M | $17.09M | -16.0 % |
| Q2 | May 11, 2026 | $17.16M | $17.19M | -0.16 % |
| Q1 | Feb 9, 2026 | $18.61M | $15.42M | 20.7 % |
| Q4 | Nov 17, 2025 | $15.13M | $15.82M | -4.41 % |